Extended-spectrum cephalosporin-resistant escherichia coli in community, specialized outpatient clinic and hospital settings in Switzerland

Journal of Antimicrobial Chemotherapy

Volumn 68, Issue 10, 2013, Pages 2249-2254

  Seiffert, Salome N ^a   Hilty, Markus ^a,b   Kronenberg, Andreas ^a,b   Droz, Sara ^a   Perreten, Vincent ^a   Endimiani, Andrea ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

AmpC; CMY; CTX M; ESBL; ST131

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE AMPC; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; QUINOLONE; QUINOLONE DERIVATIVE;

ABDOMINAL ABSCESS; ABDOMINAL DRAINAGE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CLONAL VARIATION; COMMUNICABLE DISEASE; COMMUNITY CARE; DISK DIFFUSION; DNA SEQUENCE; ESCHERICHIA COLI; EXTENDED SPECTRUM CEPHALOSPORIN RESISTANT ESCHERICHIA COLI; GENETIC ASSOCIATION; HEALTHCARE ASSOCIATED INFECTION; HOSPITAL INFECTION; HUMAN; ISOELECTRIC FOCUSING; MICROARRAY ANALYSIS; MULTILOCUS SEQUENCE TYPING; MUTATIONAL ANALYSIS; OUTPATIENT CARE; OUTPATIENT DEPARTMENT; PLASMID; POLYMERASE CHAIN REACTION; PREVALENCE; PRIMARY MEDICAL CARE; PROMOTER REGION; SWITZERLAND; URINALYSIS; URINARY TRACT INFECTION; UTERINE CERVICITIS; VULVOVAGINITIS; WILD TYPE;

AMPC; CMY; CTX-M; ESBL; ST131;

AMBULATORY CARE FACILITIES; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CEPHALOSPORINS; CHROMOSOMES; CLUSTER ANALYSIS; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DNA, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENOTYPE; HOSPITALS; HUMANS; MICROARRAY ANALYSIS; PLASMIDS; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; SWITZERLAND;

EID: 84887447739     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt208     Document Type: Article

References (22)

1. Seiffert NS, Hilty M, Perreten V et al. Extended-spectrum cephalosporin-resistant Gram-negative organisms in livestock: an emerging problem for human health? Drug Resist Updat 2013; 16: 22-45.
2. Doi Y, Park YS, Rivera JI et al. Community-associated extended-spectrum b-lactamase-producing Escherichia coli infection in the United States. Clin Infect Dis 2013; 56: 641-8.
3. Rodriguez-Bano J, Picon E, Gijon P et al. Community-onset bacteremia due to extended-spectrum b-lactamase-producing Escherichia coli: risk factors and prognosis. Clin Infect Dis 2010; 50: 40-8.
4. Rodriguez-Bano J, Alcala JC, Cisneros JM et al. Community infections caused by extended-spectrum b-lactamase-producing Escherichia coli. Arch Intern Med 2008; 168: 1897-902.
5. Qi C, Pilla V, Yu JH et al. Changing prevalence of Escherichia coli with CTX-M-type extended-spectrum b-lactamases in outpatient urinary . coli between 2003 and 2008. Diagn Microbiol Infect Dis 2010; 67: 87-91.
6. Endimiani A, Rossano A, Kunz D et al. First countrywide survey of third-generation cephalosporin-resistant Escherichia coli from broilers, swine, and cattle in Switzerland. Diagn Microbiol Infect Dis 2012; 73: 31-8.
7. Endimiani A, Hilty M, Perreten V. CMY-2-producing Escherichia coli in the nose of pigs. Antimicrob Agents Chemother 2012; 56: 4556-7.
8. Lartigue MF, Zinsius C,Wenger A et al. Extended-spectrum b-lactamases of the CTX-M type now in Switzerland. Antimicrob Agents Chemother 2007; 51: 2855-60.
9. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008; 36: 309-32.
10. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twentieth Informational Supplement M100-S20. CLSI,Wayne, PA, USA, 2010.
11. Hilty M, Betsch BY, Bogli-Stuber K et al. Transmission dynamics of extended-spectrum b-lactamase-producing Enterobacteriaceae in the tertiary care hospital and the household setting. Clin Infect Dis 2012; 55: 967-75.
12. Jorgensen RL, Nielsen JB, Friis-Moller A et al. Prevalence and molecular characterization of clinical isolates of Escherichia coli expressing an AmpC phenotype. J Antimicrob Chemother 2010; 65: 460-4.
13. Voets GM, Fluit AC, Scharringa J et al. Aset ofmultiplex PCRs for genotypic detection of extended-spectrumb-lactamases, carbapenemases, plasmidmediated AmpC b-lactamases and OXA b-lactamases. Int J Antimicrob Agents 2011; 37: 356-9.
14. Kang CI,Wi YM, Lee MY et al. Epidemiologyandrisk factors ofcommunity onset infections caused by extended-spectrum b-lactamase-producing Escherichia coli strains. J Clin Microbiol 2012; 50: 312-7.
15. European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe 2011. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). www.ecdc.europe.eu (11 March 2013, date last accessed).
16. Arpin C, Quentin C, Grobost F et al. Nationwide survey of extendedspectrum b-lactamase-producing Enterobacteriaceae in the French community setting. J Antimicrob Chemother 2009; 63: 1205-14.
17. Aguilar-Duran S, Horcajada JP, Sorli L et al. Community-onset healthcare-related urinary tract infections: comparison with community and hospital-acquired urinary tract infections. J Infect 2012; 64: 478-83.
18. den Heijer CD, Donker GA, Maes J et al. Antibiotic susceptibility of unselected uropathogenic Escherichia coli from female Dutch general practice patients: a comparison of two surveys with a 5 year interval. J Antimicrob Chemother 2010; 65: 2128-33.
19. Ho PL,Wong RC, Yip KS et al. Antimicrobial resistance in Escherichia coli outpatient urinary isolates from women: emerging multidrug resistance phenotypes. Diagn Microbiol Infect Dis 2007; 59: 439-45.
20. Kronenberg A, Koenig S, Droz S et al. Active surveillance of antibiotic resistance prevalence in urinary tract and skin infections in the outpatient setting. Clin Microbiol Infect 2011; 17: 1845-51.
21. Rodriguez-Bano J, Miro E, Villar M et al. Colonisation and infection due to Enterobacteriaceae producing plasmid-mediated AmpC b-lactamases. J Infect 2012; 64: 176-83.
22. Pluss-Suard C, Pannatier A, Kronenberg A et al. Hospital antibiotic consumption in Switzerland: comparison of a multicultural country with Europe. J Hosp Infect 2011; 79: 166-71.